Syndax Pharmaceuticals Inc at Citi Virtual Oncology Leadership Summit Transcript
Okay. This is Yigal Nochomovitz. I'm one of the biotech analysts at Citi. This is the continuation of our Virtual Oncology Summit in February. It's my pleasure to have with me from Syndax Pharmaceuticals, members of senior management including none other than Michael Metzger, the CEO; the CFO, Keith Goldan; and Briggs Morrison, President, Head of R&D. So gentlemen, thank you so much for taking a few minutes out of your schedules to chat. We really appreciate it.
Questions & Answers
Maybe, Michael, if you wouldn't mind, just for those less familiar with Syndax, just to give us a quick elevator pitch, 2 or 3 minutes just highlighting the focus of the company, your key objectives, the key programs and some of the key catalysts that you're anticipating for the balance of 2023.
Sure. Thanks, Yigal. Thanks
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
